CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.624
+0.044 (7.55%)
Mar 4, 2026, 4:00 PM EST - Market closed
CalciMedica Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CalciMedica.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for CalciMedica is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,464.10% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,464.10% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,464.10% | Mar 4, 2025 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +1,983.33% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.80M
EPS This Year
-1.60
from -1.97
EPS Next Year
-2.14
from -1.60
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | n/a | 21.0M |
| Avg | n/a | 6.8M |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.96 | -1.11 |
| Avg | -1.60 | -2.14 |
| Low | -2.10 | -2.93 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.